Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucosal melanomas.

John Tomicic1, Harold J Wanebo

  • 1Boston University, School of Medicine, 715 Albany Street, Boston, MA 02118, USA.

The Surgical Clinics of North America
|May 15, 2003
PubMed
Summary

Mucosal melanomas are rare, aggressive cancers lacking sun exposure risk factors and clear diagnostic criteria. Current treatments focus on surgery, with limited success from adjuvant therapies, necessitating further research for improved outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.

Clinical cancer research : an official journal of the American Association for Cancer Research·2014
Same author

Meeting the biologic challenge of colorectal metastases.

Clinical & experimental metastasis·2012
Same author

Trojan-horse nanotube on-command intracellular drug delivery.

Nano letters·2012
Same author

Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.

Annals of surgical oncology·2011
Same author

Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies.

Annals of surgical oncology·2011
Same author

Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck.

American journal of clinical oncology·2011

Area of Science:

  • Oncology
  • Dermatology
  • Pathology

Background:

  • Cutaneous melanoma is common with known risk factors like sun exposure.
  • Primary mucosal melanomas are rare, aggressive malignancies with unknown risk factors and poor prognosis.
  • Distinguishing primary from metastatic melanoma is diagnostically challenging.

Purpose of the Study:

  • To highlight the distinct characteristics of primary mucosal melanomas compared to cutaneous melanomas.
  • To review current understanding of risk factors, diagnosis, and treatment strategies for mucosal melanomas.
  • To emphasize the challenges in managing this rare malignancy.

Main Methods:

  • Literature review of primary mucosal melanoma characteristics, risk factors, and treatment outcomes.
  • Comparison of epidemiological data between cutaneous and mucosal melanomas.
  • Analysis of pathological and clinical diagnostic challenges.

Main Results:

  • Mucosal melanomas lack sun exposure risk factors and are often diagnosed at later stages.
  • Surgical resection remains the primary therapy, with conservative approaches gaining favor over radical surgery.
  • Adjuvant therapies, including radiotherapy, have shown limited success, particularly as prophylactic measures.

Conclusions:

  • Primary mucosal melanomas present unique challenges due to rarity and lack of identifiable risk factors.
  • Current treatment strategies offer limited improvement in prognosis, underscoring the need for novel therapeutic approaches.
  • Further research into biologic and immunologic findings is crucial for future treatment advancements.

Related Experiment Videos